| 发明名称 |
A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY |
| 摘要 |
An immunomodulator is for use in the treatment, reduction, inhibition or control of a neoplastic disease in a patient intended to undergo checkpoint inhibition therapy, simultaneously, separately or sequentially with administration of the immunomodulator. The immunomodulator preferably includes a whole cell Mycobacterium, such as M. vaccaeor M. obuense. |
| 申请公布号 |
US2017028047(A1) |
申请公布日期 |
2017.02.02 |
| 申请号 |
US201415104890 |
申请日期 |
2014.12.16 |
| 申请人 |
IMMODULON THERAPEUTICS LIMITED |
发明人 |
AKLE Charles;GRANGE John;BILYARD Kevin |
| 分类号 |
A61K39/04;A61K39/395 |
主分类号 |
A61K39/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A non-pathogenic heat killed Mycobacterium for use in the treatment, reduction, inhibition or control of a neoplastic disease in a patient intended to undergo checkpoint inhibition therapy simultaneously, separately or sequentially with administration of the Mycobacterium. |
| 地址 |
|
